Lexaria Bioscience (LEXX) Assets (2011 - 2026)
Lexaria Bioscience (LEXX) reported Assets of $4.78 million for fiscal Q3 2026 (quarter ended May 31, 2026), down 29.1% from $6.74 million a year earlier and down 26.3% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Assets (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Aug 31, 2025), Lexaria Bioscience posted Assets of $4.18 million, down 52.9% from FY2024.
- Assets has a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
- By fiscal year, Assets came in at $8.87 million in FY2024 (+187.5%), $3.08 million in FY2023 (-60.6%), $7.83 million in FY2022 (-41.0%) and $13.27 million in FY2021 (+369.1%).
- Five-year quarterly Assets spans a low of $3.08 million in fiscal Q4 2023 and a high of $13.27 million in fiscal Q4 2021.
- Year over year, Assets has now declined in each of the last five quarters, with growth averaging 27.0% over the last eight quarters.
- The high point for year-over-year Assets in five years was fiscal Q1 2022 (growth of 440.2%); the low point was fiscal Q4 2023 (a decline of 60.6%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $6.49 million (Q2 2026), $6.05 million (Q1 2026) and $4.18 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Lexaria Bioscience | 3.39 Mn | -12.26 Mn | - | 4.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 4.78 Mn |
| Feb 28, 2026 | 6.49 Mn |
| Nov 30, 2025 | 6.05 Mn |
| Aug 31, 2025 | 4.18 Mn |
| May 31, 2025 | 6.74 Mn |
| Feb 28, 2025 | 8.68 Mn |
| Nov 30, 2024 | 9.79 Mn |
| Aug 31, 2024 | 8.87 Mn |
| May 31, 2024 | 10.02 Mn |
| Feb 29, 2024 | 6.35 Mn |
| Nov 30, 2023 | 3.63 Mn |
| Aug 31, 2023 | 3.08 Mn |
| May 31, 2023 | 5.24 Mn |
| Feb 28, 2023 | 4.85 Mn |
| Nov 30, 2022 | 6.21 Mn |
| Aug 31, 2022 | 7.83 Mn |
| May 31, 2022 | 9.14 Mn |
| Feb 28, 2022 | 11.41 Mn |
| Nov 30, 2021 | 11.75 Mn |
| Aug 31, 2021 | 13.27 Mn |
API Access
Lexaria Bioscience Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();